Free Account Opening + AMC Free Demat
Loading...
July 30, 2024 - August 1, 2024

Akums Drugs and Pharmaceuticals IPO Subscription Details

Akums Drugs and Pharmaceuticals IPO Subscription Status Live

Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times. The public issue subscribed 20.80 times in the retail category, 90.09 times in QIB, and 42.10 times in the NII category by August 1, 2024 (Day 3).

Investor CategorySubscription (times)Shares OfferedShares Bid forTotal Amount (Rs Cr.)*
Qualified Institutions90.098,137,27673,31,17,77049,778.70
Non-Institutional Buyers42.104,068,63717,13,07,51011,631.78
  bNII (bids above ₹10L)47.432,712,42512,86,49,6648,735.31
  sNII (bids below ₹10L)31.451,356,2124,26,57,8462,896.47
Retail Investors20.802,712,4245,64,23,1143,831.13
Employees4.14243,90210,08,81068.50
Others[.]000
Total 63.4415,162,23996,18,57,20465,310.10

Total Application : 2,344,029 (19.01 times)

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.


Akums Drugs and Pharmaceuticals IPO (Day-wise) Subscription Details (times)

DateQIBNIIRetailEMPTotal
Day 1
July 30, 2024
0.431.973.461.111.39
Day 2
July 31, 2024
0.968.509.092.264.46
Day 3
August 1, 2024
90.0942.1020.804.1463.44

Akums Drugs and Pharmaceuticals IPO Shares Offered

Akums Drugs and Pharmaceuticals IPO is a public issue of 27,368,151 equity shares. The issue offers 2,712,424 shares to retail investors, 8,137,276 shares to qualified institutional buyers, and 4,068,637 shares to non-institutional investors.

CategoryShares OfferedAmount (Rs Cr) Size (%)
Anchor Investor12,205,912828.7844.60%
QIB8,137,276552.5229.73%
NII4,068,637276.2614.87%
    bNII (bids above ₹10L)2,712,425184.179.91%
    sNII (bids below ₹10L)1,356,21292.094.96%
Retail2,712,424184.179.91%
Employee243,90216.560.89%
Total27,368,1511,858.30100%

IPO Investor Categories

  • Qualified Institutional Buyers (QIB)

    Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.

  • Non-Institutional Investors(NII)

    Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.

    NII category has two subcategories:

    1. sNII (bids below Rs 10L)

      The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).

    2. bNII (bids above Rs 10L)

      The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).

  • Retail Individual Investors(RII)

    The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.

  • Employee (EMP)

    A category of eligible employees who have a reserved quota in the IPO.

  • Others

    A category of eligible shareholders or other investors who have a reserved quota in the IPO.

What is the difference between RII, NII, QIB and Anchor Investor?

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided here in is for informational purposes only and is provided by Chittorgarh.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Chittorgarh.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. Chittorgarh.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. Chittorgarh.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.

Akums Drugs and Pharmaceuticals IPO Subscription FAQs

The Akums Drugs and Pharmaceuticals IPO is subscribed 63.44 by August 1, 2024.

Akums Drugs and Pharmaceuticals IPO Subscription

Investor CategorySubscription (times)
Qualified Institutional90.09
Non Institutional42.10
Retail Individual20.80
Employee Reservations4.14
Others[.]
Total Subscription63.44

Retail category of Akums Drugs and Pharmaceuticals IPO subscribed 20.80 times as of date August 1, 2024. The public issue closes on August 1, 2024 for bidding.

An investor can apply in Akums Drugs and Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Akums Drugs and Pharmaceuticals IPO shares are offered online only.

The Akums Drugs and Pharmaceuticals IPO is subscribed 63.44 by August 1, 2024.

The Akums Drugs and Pharmaceuticals IPO allotment status is expected on or around August 2, 2024. Visit Akums Drugs and Pharmaceuticals IPO allotment status to check.

The Akums Drugs and Pharmaceuticals IPO listing date is Tuesday, August 6, 2024. The equity share of Akums Drugs and Pharmaceuticals Limited will list on BSE, NSE.

Visit Akums Drugs and Pharmaceuticals IPO subscription status page for real-time bidding information about Akums Drugs and Pharmaceuticals IPO.

Akums Drugs and Pharmaceuticals IPO Timetable

IPO Opens OnJuly 30, 2024
IPO Closes OnAugust 1, 2024
Finalisation of Basis of AllotmentAugust 2, 2024
Initiation of RefundsAugust 5, 2024
Credit of Shares to Demat AccountAugust 5, 2024
IPO Listing DateAugust 6, 2024